Welcome Stockaholics!

We are a new and fast growing financial forum! Sign up for free and let's talk stocks!

  1. Do you want to help develop this community? We are looking for contributions from investors and traders like you! What stocks do you follow? What is hot right now? Sign up and get in on the ground floor of the newest, fastest growing financial forum!
    Dismiss Notice
  2. You will notice a live chat widget on the right. Click in to join us and lets hear about how you nailed that last UWTI trade!
    Dismiss Notice

Aclaris Therapeutics ---ACRS

Discussion in 'Stock Message Boards NYSE, NASDAQ, AMEX' started by Biotechmaster, Sep 12, 2019 at 12:23 PM.

  1. Biotechmaster

    Biotechmaster Member

    Joined:
    Jun 3, 2016
    Messages:
    178
    Likes Received:
    5
    BRUTAL Hot Rebound Play which is massive underpriced here trading wayyy below cash

    Market Cap $43 M / Cash $115 M or untill end 2021 / 2 Marketed Products / 1 Phase 3 trial (common warts) with results expected in Q4 2019 and many other phase 2 programs / because of their strategic change they wants to out-license all their Prodcuts which means HUGE upfront payments for the company (more infos below)= CHEAPEST Biotech you can get at this time could triple easily ..

    Aclaris Therapeutics (ACRS)

    Market Cap: $43 M
    Cash: $115 M or enough untill end 2021
    Price: $1.08

    Aclaris Therapeutics Announces New Strategic Direction
    https://investor.aclaristx.com/news...herapeutics-announces-new-strategic-direction


    ACRS aquired a attractive drug from Allergan last year paid $65 m upfront alone for this drug which they now looking to outlicense .
    https://www.globenewswire.com/news-...orldwide-Rights-to-RHOFADE-from-Allergan.html


    Pipeline
    https://www.aclaristx.com/pipeline/


    Largest Shareholders:

    Deerfield Management Company LP...5 893 416
    Franklin Advisers, Inc....3 953 203
    BlackRock Fund Advisors ...2 359 223
    Broadfin Capital LLC...2 280 260
    D. E. Shaw & Co. LP....2 049 462
    Sofinnova Ventures, Inc.....1 911 573
    Vivo Capital LLC ....1 647 214
    Fidelity Management & Research Co...1 562 190
    Polar Capital LLP...1 443 920
    The Vanguard Group, Inc...1 142 022

    [​IMG]
     
  2. Biotechmaster

    Biotechmaster Member

    Joined:
    Jun 3, 2016
    Messages:
    178
    Likes Received:
    5
    the cheapest biotech you can get trading massive under cash who has 2 approved drugs and another phase 3 asset with results expected any day now ...

    Morgan Stanley reports 5% passive stake in Aclaris Therapeutics...08/29,2019
    https://thefly.com/landingPageNews.php?id=2956902


    This new strategic direction includes the following actions:

    Actively Seeking a Commercialization Partner for RHOFADE® (oxymetazoline hydrochloride) cream, 1%

    Aclaris will also seek strategic partners for ESKATA® (hydrogen peroxide) topical solution, 40% (w/w)


    Aclaris is actively seeking a strategic partner to commercialize its drug candidate A-101 45% Topical Solution, an investigational compound being developed as a potential treatment for verruca vulgaris (common warts). The Company’s two ongoing Phase 3 pivotal clinical trials, THWART-1 and THWART-2, in which A-101 45% Topical Solution is being evaluated as a potential treatment for common warts, are progressing as planned. Aclaris has completed enrollment of more than 1,000 patients across these two trials, and data from both trials are expected in the second half of 2019.

    Aclaris is actively seeking a development and commercialization partner for its drug candidates, ATI-501 (oral) and ATI-502 (topical), which are investigational Janus Kinase (JAK) 1/3 inhibitor compounds for the potential treatment of alopecia.
     
  3. Biotechmaster

    Biotechmaster Member

    Joined:
    Jun 3, 2016
    Messages:
    178
    Likes Received:
    5
  4. Biotechmaster

    Biotechmaster Member

    Joined:
    Jun 3, 2016
    Messages:
    178
    Likes Received:
    5
    Major breakout to $2+ could starty anytime now wh

    [​IMG]
     
  5. Biotechmaster

    Biotechmaster Member

    Joined:
    Jun 3, 2016
    Messages:
    178
    Likes Received:
    5
  6. Biotechmaster

    Biotechmaster Member

    Joined:
    Jun 3, 2016
    Messages:
    178
    Likes Received:
    5
    BOOOOOOOOOOOOOOOOOOOOOOOM and still trading below cash which alone is $2.80 per share
     
  7. Biotechmaster

    Biotechmaster Member

    Joined:
    Jun 3, 2016
    Messages:
    178
    Likes Received:
    5
    Exploding in pre mkt up 100% or $2.10 which is still below the $2.80 cash per share ..terrible underpriced
     

Share This Page